ClinicalTrials.gg
RecruitingNCT07716904Updated Oct 13, 2026

Whey Protein and Adaptogenic Supplementation in Physically Active Males

An interventional study of Whey protein and Dietary Supplement: Whey Protein With Adaptogenic Blend in Sports Nutritional Sciences, Sports Nutrition and Recovery, sponsored by Sports Performance and Applied Research in Trials and Analysis. Recruiting at 1 site in United Kingdom. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Sports Performance and Applied Research in Trials and Analysis · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Oct 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 390 studies in Motor Activity with a site in United Kingdom — 65 open to participants now, 79 under way, none of them phase 3. Motor Activity · United Kingdom.

Planned enrollment
104th of 318
60 · median 42
Started
2026
with 16 others
No phase
292 of 390
50 open now
Primary completion
2026-11
later than 48 of 78 live
Registered
386th of 390
by date

Among the 390 studies in Motor Activity with a site in United Kingdom, this one is the 104th largest by planned enrollment of the 318 interventional ones that give a count, is one of 17 that started in 2026, is one of 292 with no phase, reaches primary completion later than 48 of the 78 other live ones, and was the 386th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

65 of the 390 studies in Motor Activity with a site in United Kingdom are open now. Recruiting first, the newest first:

59 more — sign in →

All 65 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 45 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 390 studies in Motor Activity with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether whey protein, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active males. The adaptogenic blend contains 600mg ashwagandha root extract.The main questions the study aims to answer are:

Does whey protein improve muscle strength and recovery in physically active males? Does adding ashwagandha to whey protein further improve stress, recovery, sleep, and wellbeing compared with protein alone? Are there differences between whey protein when combined with the adaptogenic blend?

Researchers will compare two supplement groups:

  • Whey protein
  • Whey protein with ashwagandha

Participants will:

  • Take their assigned supplement for 6 weeks
  • Attend two testing sessions before and after the intervention
  • Complete questionnaires about recovery, sleep, stress, soreness, and digestive health
  • Provide saliva samples to measure stress, hormone, immune, and inflammation markers
  • Complete muscle strength tests, including handgrip strength and push-up testing
  • Complete a 24-hour dietary recall
  • The study includes physically active males aged 18 to 45 years who regularly participate in structured training.
03

Conditions studied

  • Sports Nutritional Sciences
  • Sports Nutrition
  • Recovery
  • Recovery Following Exercise
  • Muscle Strength Recovery

Browse trials for

Keywords

  • whey protein
  • ashwagandha
  • physically active males
  • sports supplement
  • adaptogens
  • exercise
  • sports nutrition
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male, aged 18-45 years
  • Currently participating in regular structured athletic or physical training (≥3 sessions per week)
  • Free from musculoskeletal injury that would prevent testing
  • Willing to maintain usual diet and training habits during the study
  • Not currently using protein supplements or adaptogenic supplements
  • Signing of form

Exclusion criteria

Exclusion Criteria:

  • Known allergy or sensitivity to dairy, ashwagandha or nightshades
  • Current use of prescribed medication that may interact with the supplements
  • Thyroid disorders, conditions, hormone-sensitive conditions, or other medical conditions
  • Diagnosed eating disorder or condition affecting protein metabolism
  • Current musculoskeletal injury preventing participation in testing
  • Current use of other protein supplements or adaptogens
  • No signing of form
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Whey protein

    Participants will consume a whey protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.

    Dietary Supplement: Whey protein

  • Experimental
    Whey Protein + Adaptogenic Blend

    Participants will consume a whey protein supplement containing ashwagandha KSM-66® (600 mg) for 6 weeks. Assessments will be conducted at baseline and post-intervention.

    Dietary Supplement: Dietary Supplement: Whey Protein With Adaptogenic Blend

Interventions

  • Dietary supplementWhey ProteinsStudies of Whey ProteinsWhey Proteins pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will consume a whey protein supplement for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.

    Also known as: Grass-Fed Whey Protein, Whey Protein Powder

  • Dietary supplementDietary Supplement: Whey Protein With Adaptogenic Blend

    Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (600 mg) for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.

    Also known as: Whey Protein Plus Adaptogens, Ashwagandha Whey Protein

06

What researchers measure

Primary outcomes

  1. Salivary Cortisol Concentration

    Change in salivary cortisol concentration from baseline to post-intervention following 6 weeks of whey protein supplementation with or without an adaptogenic herb blend containing ashwagandha KSM-66®. Results will be reported in ng/mL.

    Time frame: Time Frame: Baseline and Week 6

Secondary outcomes

  1. Handgrip Strength

    Change in maximal handgrip strength measured using a CAMRY dynamometer from baseline to post-intervention.

    Time frame: Time Frame: Baseline and Week 6

  2. Upper Body Muscular Endurance

    Change in upper body muscular endurance assessed using the 90-degree push-up test protocol from baseline to post-intervention.

    Time frame: Time Frame: Baseline and Week 6

  3. Perceived Recovery and Wellbeing

    Participants will complete the Hooper Index Questionnaire, which assesses four domains: sleep quality, fatigue, stress, and muscle soreness. Each domain is rated on a 10-point Likert scale ranging from 1 to 10, with total scores ranging from 4 to 40. Higher scores indicate poorer wellbeing and recovery status, whereas lower scores indicate better perceived wellbeing and recovery.

    Time frame: Time Frame: Baseline and Week 6

  4. Salivary DHEA-S Concentration

    Salivary DHEA-S concentration will be measured from saliva samples using enzyme-linked immunosorbent assay (ELISA) techniques. Results will be reported in ng/mL.

    Time frame: Time Frame: Baseline and Week 6

  5. Dietary Intake

    Dietary intake assessed using a 24-hour dietary recall to evaluate habitual nutritional intake during the study period.

    Time frame: Time Frame: Baseline and Week 6

  6. Salivary Testosterone Concentration

    Salivary testosterone concentration will be measured from saliva samples using ELISA. Results will be reported in pg/mL.

    Time frame: Time Frame: Baseline and Week 6

  7. Salivary Secretory Immunoglobulin A (sIgA) Concentration

    Salivary secretory immunoglobulin A (sIgA) concentration will be measured from saliva samples using ELISA. Results will be reported in µg/mL.

    Time frame: Time Frame: Baseline and Week 6

  8. Salivary C-reactive Protein Concentration

    Salivary C-reactive protein will be measured from saliva samples using ELISA. Results will be reported in pg/mL.

    Time frame: Time Frame: Baseline to Week 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with other researchers. Data collected in this study will be anonymised and retained only for the duration of analysis before permanent deletion, in accordance with the study protocol, participant consent, and UK GDPR requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Nov 2026, 4 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 4 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: primary completion Sep 2026 → Nov 2026 and completion Oct 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2026
First posted
Jul 21, 2026
StartActual
Jul 20, 2026
Primary completionEst.
Nov 20, 2026was Sep 2026
CompletionEst.
Dec 1, 2026was Oct 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 20, 2026→Nov 20, 2026
Oct 13, 2026
Study completion
Oct 1, 2026→Dec 1, 2026
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Primary completion Sep 20, 2026→Nov 20, 2026
    Study completion Oct 1, 2026→Dec 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07716904
Lead sponsor
Sports Performance and Applied Research in Trials and Analysis
Responsible party
Olivia Charlotte Coope (PhD(c), Sports Performance and Applied Research in Trials and Analysis) — Principal investigator
First posted
Jul 21, 2026
Start date
Jul 20, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Oct 13, 2026

Study contacts

Alex L Levington, PhD(c)
Contact
alex@strengthandnutrition.co.uk
07882461098
Olivia C Coope, PhD(c)
study director · Sports Performance and Applied Research in Trials and Analysis

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion